NCC Research Fund

Plans are underway for the NCC Research Fund to be subsumed under the umbrella of SingHealth Fund (SHF) as part of the NCCS Cancer Fund in the next few years. NCCS’ Community Cancer Fund was subsumed under SHF as the NCCS Cancer Fund earlier. The causes that the NCCS Cancer Fund supports remain unchanged from those as intended by NCCS for its charitable funds, namely cancer research, cancer patient support and cancer education. Donors who have been giving regularly to the NCC Research Fund will be notified in due course.

Established in 2005, the NCC Research Fund serves as the flagship fundraising and grant-making channel of our Centre by providing seeding and bridging funds for an array of translational and clinical research programmes.

The NCC Research Fund fulfils three objectives:

• Seeding funds to help our scientists’ kick-start worthy and emerging research projects. By so doing, they build a track record and would be able to apply for sustainable competitive grants from government agencies.
• Bridging funds between government grant cycles when the need arises, in order to enable our scientists to work with productive momentum.
• Advancement funds to enhance research related infrastructural capabilities, hardware, tools and processes.
  

With cancer accounting for more than one in four deaths in Singapore, the Centre plays a pivotal role in the holistic care and multidisciplinary-based treatment of cancer patients. Innovative medicine requires quality research and clinical research is an arduous undertaking. Our doctor-scientists require ample philanthropic support and public understanding in order to usher medical breakthroughs for the benefit of the community.

We firmly believe that today’s research will pave the way for a cure for cancer tomorrow.

Through your support in cancer research, there is hope of overcoming the greatest threat to lives. More lives can be saved.

NCC Research Fund is registered under the Charities Act as an Institution of Public Character (IPC) with an independent Board of Trustees.

Today's Research. Tomorrow's Cure. ™

Financial Information

Please click here to view.

Non-financial Information

(As the PDF file size is 3MB, it may take a few minutes to load.)

Charity Status

• Charity Registration No.: 01897 
• Charity Registration Date: 19 August 2005
• Gov. Instrument: Rules & Regulations
• ROS Registration No.: Not Applicable
• Date of Establishment: 6 May 2005

IPC Status

• Effective Date: 19 August 2020 to 18 August 2023
• Member of Central Fund: Health Endowment Fund

NCC Research Fund Board of Trustees​

Chairperson

NCC Research Fund Board of Trustees

Chairperson Madam Ho Geok Choo CEO, Human Capital (Singapore) Pte Ltd
Members Mr George Thia Peng Heok Business Consultant, Asiainc Private Limited and GAAB Private Limited; Non-Independent Non-Executive Director, CH Offshore Limited; Independent Non-Executive Director, Yoma Strategic Holdings Limited	Mr Kaka Singh Chairman and Senior Partner, RSM Chio Lim LLP	Mr Ng Boon Yew Chairman and CEO, Raffles Campus Pte Ltd
Prof Soo Khee Chee Surgeon, Soo Khee Chee Surgery	Prof Tan Ser Kiat Emeritus Consultant, Singapore General Hospital	Prof William Hwang  Senior Advisor, SingHealth,   Co-Director, Regenerative Medicine Institute of Singapore (REMEDIS), Senior Consultant, Department of Haematology, NCCS and SGH
Mr Harry Ng Executive Director,HLM (International) Corporate Services Pte. Ltd	Prof Lim Soon Thye  Chief Executive Officer, NCCS, & Deputy Group Chief Executive Officer (Research, Education & Innovation), SingHealth
Co-opted Members   Mr Vikna Rajah Head Tax & Trust, Co-head Private Wealth, Rajah & Tann Singapore LLP	Ms Lim Lei Theng Partner Allen & Gledhill LLP

Finance Committee

Chairperson Mr George Thia Peng Heok Business Consultant, Asiainc Private Limited and GAAB Private Limited; Non-Independent Non-Executive Director, CH Offshore Limited; Independent Non-Executive Director, Yoma Strategic Holdings Limited
Members Mr Seow Choong Huei Founder, 8818 Enterprises Private Limited	Mr Ng Boon Yew Chairman and CEO, Raffles Campus Pte Ltd	Mr Vikna Rajah Head Tax & Trust, Co-head Private Wealth, Rajah & Tann Singapore LLP

Audit & Risk Committee

Chairperson Mr Harry Ng Executive Director, HLM (International) Corporate Services Pte. Ltd
Members Mr Kaka Singh Chairman and Senior Partner, RSM Chio Lim LLP	Mr Khor Boon Hong Partner, Baker Tilly TFW LLP

Nomination Committee

 

Chairperson Prof Lim Soon Thye  CEO, NCCS
Members Prof Tan Ser Kiat Emeritus Consultant, Singapore General Hospital	Mr Suhaimi Zainul-Abidin Director/CEO, Quantedge Capital Pte Ltd	Mr Perry Lim Executive Director, Royal Golden Eagle
Madam Ho Geok Choo CEO, Human Capital (Singapore) Pte Ltd

Auditor

Ernst & Young